These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 16818658)

  • 1. CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells.
    Yang R; Cai Z; Zhang Y; Yutzy WH; Roby KF; Roden RB
    Cancer Res; 2006 Jul; 66(13):6807-15. PubMed ID: 16818658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer.
    Liu Y; Zeng B; Zhang Z; Zhang Y; Yang R
    Clin Immunol; 2008 Dec; 129(3):471-81. PubMed ID: 18790673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.
    Dolcetti L; Peranzoni E; Ugel S; Marigo I; Fernandez Gomez A; Mesa C; Geilich M; Winkels G; Traggiai E; Casati A; Grassi F; Bronte V
    Eur J Immunol; 2010 Jan; 40(1):22-35. PubMed ID: 19941314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of splenic Gr-1int immature myeloid cells in tumor-bearing mice.
    Yamamoto Y; Ishigaki H; Ishida H; Itoh Y; Noda Y; Ogasawara K
    Microbiol Immunol; 2008 Jan; 52(1):47-53. PubMed ID: 18352913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD49d is a new marker for distinct myeloid-derived suppressor cell subpopulations in mice.
    Haile LA; Gamrekelashvili J; Manns MP; Korangy F; Greten TF
    J Immunol; 2010 Jul; 185(1):203-10. PubMed ID: 20525890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.
    Haile LA; von Wasielewski R; Gamrekelashvili J; Krüger C; Bachmann O; Westendorf AM; Buer J; Liblau R; Manns MP; Korangy F; Greten TF
    Gastroenterology; 2008 Sep; 135(3):871-81, 881.e1-5. PubMed ID: 18674538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low surface expression of B7-1 (CD80) is an immunoescape mechanism of colon carcinoma.
    Tirapu I; Huarte E; Guiducci C; Arina A; Zaratiegui M; Murillo O; Gonzalez A; Berasain C; Berraondo P; Fortes P; Prieto J; Colombo MP; Chen L; Melero I
    Cancer Res; 2006 Feb; 66(4):2442-50. PubMed ID: 16489051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.
    Greifenberg V; Ribechini E; Rössner S; Lutz MB
    Eur J Immunol; 2009 Oct; 39(10):2865-76. PubMed ID: 19637228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide.
    Yanagisawa K; Exley MA; Jiang X; Ohkochi N; Taniguchi M; Seino K
    Cancer Res; 2006 Dec; 66(23):11441-6. PubMed ID: 17145891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Areca nut extracts enhance the development of CD11b(+) Gr-1(+) cells with the characteristics of myeloid-derived suppressor cells in antigen-stimulated mice.
    Wang CC; Lin HL; Liang HJ; Jan TR
    J Oral Pathol Med; 2011 Nov; 40(10):769-77. PubMed ID: 21481006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma.
    Wei S; Kryczek I; Zou L; Daniel B; Cheng P; Mottram P; Curiel T; Lange A; Zou W
    Cancer Res; 2005 Jun; 65(12):5020-6. PubMed ID: 15958543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8+ T-cell response to peptide vaccination: creation of a beneficial host microenvironment involving type I IFNs and myeloid cells.
    Salem ML; Kadima AN; El-Naggar SA; Rubinstein MP; Chen Y; Gillanders WE; Cole DJ
    J Immunother; 2007 Jan; 30(1):40-53. PubMed ID: 17198082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-conditioned Gr-1(+)CD11b(+) myeloid cells induce angiogenesis through the synergistic action of CCL2 and CXCL16 in vitro.
    Han EC; Lee J; Ryu SW; Choi C
    Biochem Biophys Res Commun; 2014 Jan; 443(4):1218-25. PubMed ID: 24388986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic ethanol ingestion by mice increases expression of CD80 and CD86 by activated macrophages.
    Zhu X; Coleman RA; Alber C; Ballas ZK; Waldschmidt TJ; Ray NB; Krieg AM; Cook RT
    Alcohol; 2004 Feb; 32(2):91-100. PubMed ID: 15163560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of myeloid-derived suppressor cells and T regulatory cells in lung microenvironment after Urethane-induced lung tumor.
    Rosin FC; Pedregosa JF; de Almeida JS; Bueno V
    Int Immunopharmacol; 2011 Jul; 11(7):873-8. PubMed ID: 21238620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-specific immunity and cross-priming by epithelial ovarian carcinoma-induced CD11b(+)Gr-1(+) cells.
    Tomihara K; Guo M; Shin T; Sun X; Ludwig SM; Brumlik MJ; Zhang B; Curiel TJ; Shin T
    J Immunol; 2010 Jun; 184(11):6151-60. PubMed ID: 20427766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal Echinococcus multilocularis infection in C57BL/6 mice affects CD40 and B7 costimulator expression on peritoneal macrophages and impairs peritoneal T cell activation.
    Mejri N; Gottstein B
    Parasite Immunol; 2006 Aug; 28(8):373-85. PubMed ID: 16879309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of immune responses in collagen-induced arthritis by a rationally designed CD80-binding peptide agent.
    Srinivasan M; Eri R; Zunt SL; Summerlin DJ; Brand DD; Blum JS
    Arthritis Rheum; 2007 Feb; 56(2):498-508. PubMed ID: 17265485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of arginase I activity and expression by both PD-1 and CTLA-4 on the myeloid-derived suppressor cells.
    Liu Y; Yu Y; Yang S; Zeng B; Zhang Z; Jiao G; Zhang Y; Cai L; Yang R
    Cancer Immunol Immunother; 2009 May; 58(5):687-97. PubMed ID: 18828017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host.
    Huang B; Pan PY; Li Q; Sato AI; Levy DE; Bromberg J; Divino CM; Chen SH
    Cancer Res; 2006 Jan; 66(2):1123-31. PubMed ID: 16424049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.